References

Tanshinone IIA exhibits anticonvulsant activity in zebrafish and mouse seizure models

10.1021/cn400140e · 2013 · External reference

Tanshinone IIA modulates low density lipoprotein uptake via down-regulation of PCSK9 gene expression in HepG2 cells

10.1371/journal.pone.0162414 · 2016 · External reference

Quantitative proteomics reveal the role of matrine in regulating lipid metabolism

10.1021/acsomega.3c09983 · 2024 · External reference

Traditional Chinese Medicine Diagnosis and Treatment Guidelines for Stable Angina Pectoris of Coronary Heart Disease

2019 · External reference

Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019

10.1016/s0140-6736(20)30925-9 · 2020 · External reference

Construction and application evaluation of a risk prediction model for rehospitalization in patients with stable angina pectoris due to coronary heart disease: a prospective study based on real-world clinical data

10.13288/j.11-2166/r.2025.06.010 · 2025 · External reference

Effects of an enriched extract of paeoniflorin, a monoterpene glycoside used in Chinese herbal medicine, on cholesterol metabolism in a hyperlipidemic rat model

10.12659/msm.905544 · 2017 · External reference

Research progress on the mechanism of astragalus and its active components in the prevention and treatment of atherosclerosis by regulating lipid metabolism

10.3389/fcvm.2023.1137778 · 2023 · External reference

Risk prediction model for major adverse cardiovascular events (MACE) during hospitalization in patients with coronary heart disease based on myocardial energy metabolic substrate

10.3389/fcvm.2023.1137778 · 2023 · External reference

Research progress on the pathogenesis of stable coronary artery disease and its treatment with traditional Chinese medicine

10.13862/j.cn43-1446/r.2024.06.026 · 2024 · External reference

Progress in revascularization strategies for stable coronary artery disease: interpretation of the 2018 Chinese guidelines for the diagnosis and treatment of stable coronary artery disease

2019 · External reference

Ezetimibe alone for over 75 years old as a primary prevention to decrease cardiovascular events

10.1080/07853890.2026.2634484 · 2026 · External reference

Research progress of traditional Chinese medicine in the treatment of atherosclerotic cardiovascular disease from Qi deficiency and blood stasis

2025 · External reference

Development and validation of a risk nomogram model for predicting revascularization after percutaneous coronary intervention in patients with acute coronary syndrome

10.2147/cia.s325385 · 2021 · External reference

Theoretical discussion on the treatment of stable coronary artery disease by the method of harmonizing Qi and blood

10.16254/j.cnki.53-1120/r.2025.07.003 · 2025 · External reference

Research progress on herb pairs of Astragalus combined with Qi-replenishing, blood-activating, and blood-nourishing herbs

10.16367/j.issn.1003-5028.2021.08.0291 · 2021 · External reference

Research progress on the Astragalus-Salvia herb pair in the prevention and treatment of cardiovascular diseases

10.13375/j.cnki.wcjps.2025.01.021 · 2025 · External reference

Chromatin modification by lipids and lipoprotein components: an initiating event in atherogenesis?

10.1097/01.mol.0000180165.70077.ee · 2005 · External reference

Unresolved reference

2024 · External reference

MiR-483-5p downregulation alleviates ox-LDL induced endothelial cell injury in atherosclerosis

10.1186/s12872-023-03496-1 · 2023 · External reference